Phase 3 Study; Effects of Green Tea Extract on Obese Women With High Level of Low Density Lipoprotein (LDL): a Randomized, Double-blinded, and Cross-over Placebo-controlled Clinical Trial
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Enrollment
- 73
- Locations
- 2
- Primary Endpoint
- percentage of reduction of LDL-C
Study Overview
Brief Summary
Green tea is one of the most popular beverages in the world. It is believed to have beneficial effect in prevention and treatment of many diseases, one of which is reducing LDL-C. The aim of the study is to examine the effect of supplement containing GTE on obese with high LDL level.
Detailed Description
Randomized, double-blind, crossover placebo-controlled clinical trial
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •age between 18 and 65 years
- •body mass index (BMI) >= 27 kg/m2
- •fasting low-density-lipoprotein cholesterol (LDL) >= 130mg/dl and (4) willing to participate in this trial.
Exclusion Criteria
- •serum alanine transaminase > 80 U/L
- •serum creatinine > 1.8 mg/dl
- •breast feeding or pregnancy
- •heart failure, acute myocardial infarction, stroke, heavy injury
- •any other conditions not suitable for trial as evaluated by the physician. -
Outcomes
Primary Outcomes
percentage of reduction of LDL-C
Time Frame: 6 weeks of treatment
level of LDL-C before intervention minus level of LDL-C after intervention equal to reduction of LDL-C, percentage of reduction of LDL-C equal to the level of reduction of LDL-C divided by level of LDL-C before intervention
Secondary Outcomes
- HDL-C(6 weeks)
Investigators
Chung-Hua Hsu
Dr
National Yang Ming Chiao Tung University
